First Myanmar Investment Pharma
FMI グループの医薬品事業は、ジェネリック医薬品とヘルスケア製品を製造しています。
ファースト ミャンマー インベストメントの製薬子会社は、国内流通向けにジェネリック医薬品と健康補助食品を製造しています。病院のサプライチェーンや小売薬局ネットワークを通じて販売されます。
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Yangon, Myanmar
- Founded
- 2012
- Website
- https://www.fmi.com.mm
- Categories
- 医療およびヘルスケア用品
- Markets
- ミャンマー (ビルマ)
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- web-presence-since (green), checked 2026-08-08 Internet Archive (Wayback)
- sanctions-clear (green), checked 2026-08-08 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- debarment-clear (green), checked 2026-08-08 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
Claimed certifications, not confirmed by us
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)